Dr Juliet Brock

Dr Juliet Brock
BMBCh, MA(Oxon), MRCP, FRCR, MD(Res) Clinical Oncologist

Languages spoken


Expert in

Non-surgical management of central nervous system tumours


Dr Juliet Brock specialises in the non-surgical management of central nervous system tumours.

Towards the end of her Clinical Oncology Training, she undertook a post-graduate research degree at the Institute of Cancer Research and Royal Marsden Hospital focussing on technical radiotherapy. Dr Brock was subsequently appointed to a senior clinical fellow post specialising in the management of brain metastases, in particular the use of stereotactic radiotherapy (SRS).

She was appointed to a consultant post treating CNS and lung cancer at the Sussex Cancer Centre in 2011. During that post she remained active in clinical research, with a particular interest in glioma in the older person. Dr Brock supervised a research fellow undertaking an MD and has formed a successful national research collaboration, as well as being a local principal investigator for brain tumour trials. In 2022 she was appointed chair of a National Cancer Research Institute (NCRI) brain tumour working group tasked with improving outcomes for older and frail brain tumour patients.

In September 2022, Dr Brock took up a new consultant Neuro-oncology post at Oxford University Hospitals. Her aim is to provide excellent compassionate care to all patients with central nervous system tumours, delivering high quality technical radiotherapy and evidence-based systemic treatment. A specific focus will be improving the multi-disciplinary management of brain metastases.

Career positions

Current position(s)

  • Neuro-Oncologist, Oxford University Hospitals NHS Foundation Trust

Expertise and interests


  • Non-surgical management of low and high grade tumours of the brain and spinal cord
  • SRS for brain metastases
  • Radiotherapy for pituitary tumours and vestibular schwannoma
  • Glioblastoma multiforme (GBM) 
  • Brain tumours and brain metastases

Professional association

  • Fellow of the Royal College of Radiologists (RCR)
  • Member of the British Neuro-Oncology Society (BNOS)
  • Member of the British Medical Association (BMA)



  • Cressida F Lorimer, Gill Walsh, Mairi MacKinnon, Alison Corbett, Katie Bedborough, Kathy Greenwood, Frank Saran, Anthony J Chalmers, Juliet Brock. Geriatric assessment of glioblastoma patients is feasible and may provide useful prognostic information.Neuro-Oncology Practice 7(2), April 2020; 176–184J.
  •  Ming Yao Chong, Cressida F Lorimer, Shaveta Mehta, Ehab Ibrahim, Juliet Brock, Catherine McBain, Philip McLoone & Anthony J ChalmersAn audit of the management of elderly patients with glioblastoma in the UK: have recent trial results changed treatment?CNS Oncology (2019)8(4)
  •  C.F. Lorimer, C. Hanna, F. Saran, A. Chalmers and J. Brock. Challenges to treating older glioblastoma patients: the influence of clinical and tumour characteristics on survival outcomes. Clinical Oncology (R Coll Radiol). 2017 Nov;29(11):739-747
  •  Lorimer, Chalmers, Saran, Brock J. Glioblastoma in the elderly — How do we choose who to treat? J of Geriatric Oncology 2016 Nov;7(6):453-456
  • K. Marchon and J. Brock. Steroid induced Osteoporosis in Glioblastoma Multiforme Patients. Poster at BNOS 2021